enfermedades sistémicas

Area Manager: Irene Diez Itza M.D., Ph.D.

Donostialdea IHO

The general objective in this area is to involve professionals at the Donostia University Hospital in research studies, and to establish and strengthen existing lines of research.

The Research Groups carry out a wide range of activities, which can be divided into five parts:

Line of research into Heart Failure caused by Hypertension, studying the predictive value of new biomarkers in heart failure with hypertension and valvular causes, and which has embarked on new lines of research on fibrosis associated with the ageing process, and in particular in patients with degenerative aortic valve disease associated with ageing.

The Obstetrics and Gynaecology line of research, which covers both prenatal diagnosis, the development of new diagnostic techniques for foetal, maternal and neonatal complications in pregnancy and childbirth.

Otorhinolaryngology and Head and Neck Surgery comprises the raft of theoretical and practical knowledge required for the medical and surgical diagnosis and treatment of infectious, oncology, traumatic, congenital and degenerative pathology of the ear, pharynx, larynx, nostrils, sinus and other cervicofacial structures.

Paediatrics line of research is a very wide-ranging area with myriad specialities, but there are certain common areas. It mainly studies rare or minority diseases (ERDs) in children, child development and its disorders and other mainly pediatric diseases such as infant asthma or pediatric infectious diseases.

The main objective of the Respiratory and Pleural Pathology Research Group is to take its first steps as a new Group in the field of respiratory disease, increasing, in the long term, the reach of the related Services offered to its patients by the Basque Health Service – Osakidetza. Among the Group’s strategic objectives are to create a biobank of pulmonary and pleural samples and an associated database, and to address aspects associated to both pathologies, such as the design of devices and the validation of patient screening systems.